118 related articles for article (PubMed ID: 1949676)
1. [The effect of a structural analog of gamma-butyrobetaine, mildronate, [3-2,2,2-trimethylhydrazine)propionate] on dynamic carnitine-dependent metabolism].
Shutenko ZhV; Priedena IA; Kalvin'sh IIa; Lukevits EIa
Vopr Med Khim; 1991; 37(3):24-6. PubMed ID: 1949676
[TBL] [Abstract][Full Text] [Related]
2. [Effect of a new structural analog of gamma-butyrobetaine-- 3-(2,2,2-trimethylhydrazine)propionate (THP) on carnitine level, carnitine-dependent fatty acid oxidation and various indices of energy metabolism in the myocardium].
Simkhovich BZ; Meĭrena DV; Khagi KhB; Kalvin'sh IIa; Lukevits EIa
Vopr Med Khim; 1986; 32(4):72-6. PubMed ID: 3765501
[TBL] [Abstract][Full Text] [Related]
3. [The effect of mildronate on disorders of the cardiac contractile function in rats caused by an excess of free fatty acids and ischemia].
Simkhovich BZ; Briede IaL; Ozola RA; Meĭrena DV; Kalvin'sh IIa; Lukevits EIa
Farmakol Toksikol; 1990; 53(5):27-9. PubMed ID: 2253743
[TBL] [Abstract][Full Text] [Related]
4. [Potentiation of the antiketogenic effect of exogenous glucose with the help of the new beta-oxidation inhibitor mildronate--3-(2,2,2-trimethylhydrazine)propionate].
Shutenko ZhV; Meĭrena DV; Kalvin'sh IIa; Lukevits EIa
Vopr Med Khim; 1991; 37(2):59-60. PubMed ID: 1897198
[TBL] [Abstract][Full Text] [Related]
5. [Effect of DL-carnitine and gamma-butyrobetaine hydroxylase inhibitor 3-(2,2,2-trimethylhydrazinium) propionate on isoproterenol-induced changes in the metabolism of the rat myocardium].
Simkhovich BZ; Meĭrena DV; Shutenko ZhV; Khagi KhB; Briede IaL
Vopr Med Khim; 1988; 34(5):30-4. PubMed ID: 3218133
[TBL] [Abstract][Full Text] [Related]
6. [The effect of mildronate on carnitine-dependent and carnitine-independent ketogenesis in rats].
Simkhovich BZ; Meĭrena DV; Khagi KhB; Shutenko ZhV; Molodchina TN; Kalvin'sh IIa; Lukevits EIa
Farmakol Toksikol; 1991; 54(4):41-2. PubMed ID: 1786824
[TBL] [Abstract][Full Text] [Related]
7. [Study of the effect of an inhibitor of carnitine-dependent metabolism of mildronate on the oxidation of fatty acids in the liver mitochondria of intact rats].
Kagan TI; Simkhovich BZ; Kalvinysh IIa; Lukevits EIa
Vopr Med Khim; 1991; 37(2):44-6. PubMed ID: 1897193
[TBL] [Abstract][Full Text] [Related]
8. [Regulation of carnitine-dependent metabolism of fatty acids in the rat myocardium using 3-(2,2,2-trimethylhydrazinium) propionate].
Shutenko ZhV; Simkhovich BZ; Meĭrena DV; Kalvin'sh IIa; Lukevits EIa
Vopr Med Khim; 1989; 35(2):59-64. PubMed ID: 2741413
[TBL] [Abstract][Full Text] [Related]
9. [Biochemical characteristics of the anti-ischemic action of the new structural analog of gamma-butyrobetaine 3-(2,2,2,-trimethylhydrazine)propionate].
Simkhovich BZ; Meĭrena DV; Khagi KhB; Kalvin'sh IIa; Lukevits EIa
Farmakol Toksikol; 1987; 50(2):100-4. PubMed ID: 3582624
[TBL] [Abstract][Full Text] [Related]
10. Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction.
Liepinsh E; Vilskersts R; Loca D; Kirjanova O; Pugovichs O; Kalvinsh I; Dambrova M
J Cardiovasc Pharmacol; 2006 Dec; 48(6):314-9. PubMed ID: 17204911
[TBL] [Abstract][Full Text] [Related]
11. [The effect of the carnitine biosynthesis inhibitor mildronate on the lipid metabolic indices of rats].
Shutenko ZhV; Priedena IA; Mezhapuke RIa; Simkhovich BZ; Kalvin'sh IIa; Lukevits EIa
Farmakol Toksikol; 1991; 54(2):55-6. PubMed ID: 1884799
[TBL] [Abstract][Full Text] [Related]
12. 3-(2,2,2-Trimethylhydrazinium)propionate (THP)--a novel gamma-butyrobetaine hydroxylase inhibitor with cardioprotective properties.
Simkhovich BZ; Shutenko ZV; Meirena DV; Khagi KB; Mezapuķe RJ; Molodchina TN; Kalviņs IJ; Lukevics E
Biochem Pharmacol; 1988 Jan; 37(2):195-202. PubMed ID: 3342076
[TBL] [Abstract][Full Text] [Related]
13. Carnitine depletion in rat pups from mothers given mildronate: a model of carnitine deficiency in late fetal and neonatal life.
Peschechera A; Scalibastri M; Russo F; Giarrizzo MG; Carminati P; Giannessi F; Arduini A; Ricciolini R
Life Sci; 2005 Oct; 77(24):3078-91. PubMed ID: 15979102
[TBL] [Abstract][Full Text] [Related]
14. The cardioprotective effect of mildronate is diminished after co-treatment with L-carnitine.
Kuka J; Vilskersts R; Cirule H; Makrecka M; Pugovics O; Kalvinsh I; Dambrova M; Liepinsh E
J Cardiovasc Pharmacol Ther; 2012 Jun; 17(2):215-22. PubMed ID: 21903968
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of activities relative to fatty acid oxidation in the liver of rats depleted of L-carnitine by D-carnitine and a gamma-butyrobetaine hydroxylase inhibitor.
Tsoko M; Beauseigneur F; Gresti J; Niot I; Demarquoy J; Boichot J; Bezard J; Rochette L; Clouet P
Biochem Pharmacol; 1995 May; 49(10):1403-10. PubMed ID: 7763283
[TBL] [Abstract][Full Text] [Related]
16. Interaction of mildronate with the mitochondrial carnitine/acylcarnitine transport protein.
Oppedisano F; Fanello D; Calvani M; Indiveri C
J Biochem Mol Toxicol; 2008 Feb; 22(1):8-14. PubMed ID: 18273902
[TBL] [Abstract][Full Text] [Related]
17. Carnitine transport into muscular cells. Inhibition of transport and cell growth by mildronate.
Georges B; Le Borgne F; Galland S; Isoir M; Ecosse D; Grand-Jean F; Demarquoy J
Biochem Pharmacol; 2000 Jun; 59(11):1357-63. PubMed ID: 10751544
[TBL] [Abstract][Full Text] [Related]
18. [Prevention of ischemic myocardial damage by reducing the intracellular free carnitine level].
Simkhovich BZ; Vitolinia RO; Stivrinia MI; Shutenko ZhV; Meĭrena DV
Kardiologiia; 1987 Jul; 27(7):85-8. PubMed ID: 3656926
[TBL] [Abstract][Full Text] [Related]
19. A fatty acid analogue targeting mitochondria exerts a plasma triacylglycerol lowering effect in rats with impaired carnitine biosynthesis.
Lindquist C; Bjørndal B; Rossmann CR; Svardal A; Hallström S; Berge RK
PLoS One; 2018; 13(3):e0194978. PubMed ID: 29590220
[TBL] [Abstract][Full Text] [Related]
20. Endothelium- and nitric oxide-dependent vasorelaxing activities of gamma-butyrobetaine esters: possible link to the antiischemic activities of mildronate.
Sjakste N; Kleschyov AL; Boucher JL; Baumane L; Dzintare M; Meirena D; Sjakste J; Sydow K; Münzel T; Kalvinsh I
Eur J Pharmacol; 2004 Jul; 495(1):67-73. PubMed ID: 15219822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
